Clinical Trial Update: The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

View source ↗

Summary

The trial evaluating whether interim PET/CT after two cycles of chemotherapy can predict progression in non-Hodgkin lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Lymphoma; Large Cell (Diffuse) With Small Cell, Diffuse | Status: WITHDRAWN